首页> 外文期刊>世界急诊医学杂志(英文版) >A single subcutaneous dose of tramadol for mild to moderate musculoskeletal trauma in the emergency department
【24h】

A single subcutaneous dose of tramadol for mild to moderate musculoskeletal trauma in the emergency department

机译:一种皮下剂量的曲马多,用于轻度至中等肌肉骨骼创伤的急诊部

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Mild to moderate musculoskeletal trauma is a common cause for anemergency room visit, and frequent pain is one of the cardinal symptoms of consultation. Theobjective of this study is to assess the perception of a single subcutaneous dose of 50 mg tramadolfor pain management in patients with mild to moderate musculoskeletal trauma, likewise to appraisethe perception of pain by subcutaneous injection.METHODS: A total of 77 patients, who met inclusion criteria, received a single subcutaneousdose of tramadol. Pain control was evaluated based on the verbal numerical pain scale (0-10) atbaseline, 20 and 60 minutes; similarly, pain perception was evaluated secondary to subcutaneousinjection of the analgesic.RESULTS: On admission, the average pain perceived by patients was 8; twenty minutes later,89% of the patients reported fi ve or less, and after sixty minutes, 94% had three or less on the verbalnumerical pain scale. Of the patients, 88% reported pain perception by verbal numeric scale of 3 orless by injection of the drug, and 6.5% required a second analgesic for pain control. Two events withdrug administration (soft tissue infection and mild abdominal rectus injection) were reported.CONCLUSION: We conclude that a single subcutaneous dose of tramadol is a safe andeffective option for the management of patients with mild to moderate pain and musculoskeletaldisease in the emergency department.
机译:背景:轻度至中度肌肉骨骼创伤是一次性机动室访问的常见原因,频繁的痛苦是咨询的主要症状之一。本研究的主题是评估轻度至中度肌肉骨骼创伤患者的单一皮下剂量为50毫克曲马多的疼痛管理,同样估计皮下注射疼痛的感知。方法:共有77名患者,符合纳入标准,接受曲马多的单个蛛网膜。基于口头数值疼痛规模(0-10)阿塔基斯,20和60分钟评估疼痛对照;类似地,评估止痛性的疼痛感知对镇痛药的次要反映。结果:在入院时,患者感知的平均疼痛是8;二十分钟后,89%的患者报告过五个或更低,六十分钟后,94%的舌头痛尺度有三个或更少。在患者的情况下,88%通过注射药物口头数尺度令人痛苦的疼痛感知,6.5%需要第二次止痛药。报告了两种事件(软组织感染和轻度腹部浸渍)。结论:我们得出结论,曲马多的单一皮下剂量是一种安全无效的选择,用于在急诊部门的患者中管理轻度至中度疼痛和肌肉脑骨骼患者。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号